- Home
- TWIN vs FENC Comparison
TWIN vs FENC Comparison
Compare TWIN & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWIN
- FENC
- Stock Information
- Founded
- TWIN 1918
- FENC 1996
- Country
- TWIN United States
- FENC United States
- Employees
- TWIN N/A
- FENC N/A
- Industry
- TWIN Industrial Machinery/Components
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TWIN Industrials
- FENC Health Care
- Exchange
- TWIN Nasdaq
- FENC Nasdaq
- Market Cap
- TWIN 186.2M
- FENC 225.4M
- IPO Year
- TWIN N/A
- FENC 2001
- Fundamental
- Price
- TWIN $13.23
- FENC $8.78
- Analyst Decision
- TWIN Strong Buy
- FENC Strong Buy
- Analyst Count
- TWIN 1
- FENC 2
- Target Price
- TWIN $12.00
- FENC $13.50
- AVG Volume (30 Days)
- TWIN 63.0K
- FENC 56.2K
- Earning Date
- TWIN 11-05-2025
- FENC 11-06-2025
- Dividend Yield
- TWIN 1.18%
- FENC N/A
- EPS Growth
- TWIN N/A
- FENC N/A
- EPS
- TWIN N/A
- FENC N/A
- Revenue
- TWIN $340,738,000.00
- FENC $33,302,000.00
- Revenue This Year
- TWIN $10.79
- FENC $0.96
- Revenue Next Year
- TWIN $8.43
- FENC $51.71
- P/E Ratio
- TWIN N/A
- FENC N/A
- Revenue Growth
- TWIN 15.46
- FENC N/A
- 52 Week Low
- TWIN $6.16
- FENC $3.96
- 52 Week High
- TWIN $13.80
- FENC $9.42
- Technical
- Relative Strength Index (RSI)
- TWIN 67.63
- FENC 50.56
- Support Level
- TWIN $12.79
- FENC $8.42
- Resistance Level
- TWIN $13.77
- FENC $9.11
- Average True Range (ATR)
- TWIN 0.60
- FENC 0.31
- MACD
- TWIN -0.05
- FENC -0.03
- Stochastic Oscillator
- TWIN 68.33
- FENC 41.71
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.